Thu, Nov 21, 2024
[Archive]
Volume 14, Issue 1 ( March 2022 2022)
Iranian Journal of Blood and Cancer 2022, 14(1): 40-43 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Mohammadi Moghaddam S, Maghsoudlou S, Choubdar H, Mahdavi M, Nikoogadam M. Recurrent Pneumothorax and Pneumomediastinum as a Complication of COVID-19 in a Young Athlete. Iranian Journal of Blood and Cancer 2022; 14 (1) :40-43
URL: http://ijbc.ir/article-1-1247-en.html
URL: http://ijbc.ir/article-1-1247-en.html
Soha Mohammadi Moghaddam1 
, Sina Maghsoudlou1 , Hadi Choubdar2 , Mahdi Mahdavi2 , Mojtaba Nikoogadam * 3
, Sina Maghsoudlou1 , Hadi Choubdar2 , Mahdi Mahdavi2 , Mojtaba Nikoogadam * 3
1- Pediatric Congenital Hematologic Disorders Research Center, Research Institute for Children’s health, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2- School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3- Department of Internal Medicine, Shohadaye Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2- School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3- Department of Internal Medicine, Shohadaye Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Abstract: (1688 Views)
A novel coronavirus, SARS-CoV-2 was identified as the cause of a cluster of pneumonia cases in Wuhan, China in December 2019. Coronavirus Disease 2019 (COVID-19) has rapidly spread worldwide. Numerous studies have shown diverse findings on chest CT scan of the patients with COVID-19. The established well-known features of COVID-19 on chest imaging include bilateral multilobar ground-glass opacification (GGO) predominantly with peripheral distribution, mainly in the lower lobes. Atypical presentation of consolidative opacities superimposed on GGO may be found in a smaller number of cases, mainly in the elderly populations. Pleural and pericardial effusion, lymphadenopathy, cavitation, halo sign on CT scan, and pneumothorax are uncommon but may be seen with disease progression.
We report a case of severe COVID-19 in an athlete man with development of bilateral pneumothorax, pneumomediastinum and subcutaneous emphysema during progression of the disease. The only risk factor for severe COVID-19 in our patient was suggested to be chronic use of dexamethasone as anabolic steroids. Our patient also received three sessions of plasmapheresis. Unfortunately, the patient expired due to recurrence of bilateral pneumothorax and pneumomediastinum.
: Case report |
Subject:
Adults Hematology & Oncology
Received: 2022/04/30 | Accepted: 2022/03/10 | Published: 2022/04/30
Received: 2022/04/30 | Accepted: 2022/03/10 | Published: 2022/04/30
References
1. Number of novel coronavirus (COVID-19) deaths worldwide as of April 11, 2022, by country. https://www.statista.com/statistics/1093256/novelcoronavirus-2019ncov-deaths-worldwide-bycountry/.
2. da Rosa Mesquita R, Francelino Silva Junior LC, Santos Santana FM, Farias de Oliveira T, Campos Alcantara R, Monteiro Arnozo G, et al. Clinical manifestations of COVID-19 in the general population: systematic review. Wien Klin Wochenschr. 2021;133(7-8):377-82.. [DOI:10.1007/s00508-020-01760-4]
3. Zhu J, Ji P, Pang J, Zhong Z, Li H, He C, et al. Clinical characteristics of 3062 COVID-19 patients: A meta-analysis. J Med Virol. 2020;92(10):1902-14. [DOI:10.1002/jmv.25884]
4. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. jama. 2020;323(13):1239-42. [DOI:10.1001/jama.2020.2648]
5. Keith P, Day M, Perkins L, Moyer L, Hewitt K, Wells A. A novel treatment approach to the novel coronavirus: an argument for the use of therapeutic plasma exchange for fulminant COVID-19. Vol 24: BioMed Central; 2020:1-3. [DOI:10.1186/s13054-020-2836-4]
6. Balagholi S, Dabbaghi R, Eshghi P, Mousavi SA, Heshmati F, Mohammadi S. Potential of therapeutic plasmapheresis in treatment of COVID-19 patients: Immunopathogenesis and coagulopathy. Transfusion and Apheresis Science. 2020;59(6):102993. [DOI:10.1016/j.transci.2020.102993]
7. Beraud M, Al Hashami S, Lozano M, Bah A, Keith P. Role of therapeutic plasma exchange in the management of COVID-19-induced cytokine storm syndrome. Transfusion and Apheresis Science. 2022:103433. [DOI:10.1016/j.transci.2022.103433]
8. Yao W, Wang T, Jiang B, Gao F, Wang L, Zheng H, et al. Emergency tracheal intubation in 202 patients with COVID-19 in Wuhan, China: lessons learnt and international expert recommendations. Br J Anaesth. 2020;125(1):e28-e37.
9. Jacobi A, Chung M, Bernheim A, Eber C. Portable chest X-ray in coronavirus disease-19 (COVID-19): A pictorial review. Clin Imaging. 2020;64:35-42. [DOI:10.1016/j.clinimag.2020.04.001]
10. Quincho-Lopez A, Quincho-Lopez DL, HurtadoMedina FD. Case report: pneumothorax and pneumomediastinum as uncommon complications of COVID-19 pneumonia-literature review. The American journal of tropical medicine and hygiene. 2020;103(3):1170. [DOI:10.4269/ajtmh.20-0815]
11. Lal A, Mishra AK, Akhtar J, Nabzdyk C. Pneumothorax and pneumomediastinum in COVID19 acute respiratory distress syndrome. Monaldi Arch Chest Dis. 2021;91(2). [DOI:10.4081/monaldi.2021.1608]
12. Pribble C, Berg M. Pneumothorax as a complication of bilevel positive airway pressure (BiPAP) ventilation. Clinical Intensive Care. 2000;11(3):145-7. [DOI:10.3109/tcic.11.3.145.147]
13. Sihoe AD, Wong RH, Lee AT, Lau LS, Leung NY, Law KI, et al. Severe acute respiratory syndrome complicated by spontaneous pneumothorax. Chest. 2004;125(6):2345-51. [DOI:10.1378/chest.125.6.2345]
14. Salehi S, Abedi A, Balakrishnan S, Gholamrezanezhad A. Coronavirus Disease 2019 (COVID-19): A Systematic Review of Imaging Findings in 919 Patients. AJR Am J Roentgenol. 2020;215(1):87- 93. [DOI:10.2214/AJR.20.23034]
15. Taha Mallick AD, Engdahl R, Sabado M. COVID-19 Complicated by Spontaneous Pneumothorax. 2020. [DOI:10.7759/cureus.9104]
16. Ledford H. Steroid is first drug shown to prevent deaths from Covid-19. Nature. 2020;582(7813):469-. [DOI:10.1038/d41586-020-01824-5]
17. Hu B, Huang S, Yin L. The cytokine storm and COVID‐19. Journal of medical virology. 2021;93(1):250-6. [DOI:10.1002/jmv.26232]
18. Organization WH. Therapeutics and COVID-19: living guideline, 7 December 2021. World Health Organization;2021.
19. Pereira MR, Mohan S, Cohen DJ, Husain SA, Dube GK, Ratner LE, et al. COVID-19 in solid organ transplant recipients: Initial report from the US epicenter. Am J Transplant. 2020;20(7):1800-8. [DOI:10.1111/ajt.15941]
20. Han Y, Jiang M, Xia D, He L, Lv X, Liao X, et al. COVID-19 in a patient with long-term use of glucocorticoids: a study of a familial cluster. Clinical Immunology. 2020;214:108413. [DOI:10.1016/j.clim.2020.108413]
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
- Iranian Journal of Blood and Cancer
- Journal Tel: +989369936116
- Publisher Tel: +982122275917
- Mail: Info@ijbc.ir
